Naomi Patel MD

Dr. Naomi Patel was born in Chapel Hill, North Carolina and grew up in San Diego, California. She graduated summa cum laude from the University of California, Los Angeles, where she studied Biochemistry. She obtained her medical degree from the University of California, Los Angeles, David Geffen School of Medicine, completed her internship and residency in Internal Medicine at Stanford, and served as a Chief Resident for an additional year. She moved to the east coast and completed her rheumatology fellowship training at Massachusetts General Hospital (MGH). She is currently a Graduate Assistant in the Division of Rheumatology, Allergy and Immunology at MGH and an Instructor at Harvard Medical School.

Dr. Patel’s clinical and research interests include quantifying and assessing glucocorticoid toxicity across rheumatic diseases, studying the clinical outcomes of patients with rheumatic disease and COVID-19 infection, and evaluating infectious disease screening prior to biologic use. She has served as an investigator in multiple clinical trials including evaluating the impact of tocilizumab on outcomes of COVID-19 as well as a current randomized trial evaluating the efficacy of holding immunosuppressive medications around the time of a SARS-CoV-2 booster vaccine.

At MGH, she has served as the Chair of the Women in Medicine Trainees’ Council and as a fellow representative on the Housestaff Quality and Patient Safety Committee. She has attended multiple advocacy events hosted by the American College of Rheumatology (ACR) and looks forward to remaining involved in ACR.